osthol has been researched along with Cancer of Ovary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Huang, W; Huang, X; Li, H; Liang, J; Wang, X; Xu, Y; Zhou, J | 1 |
Bae, H; Lee, JY; Lim, W; Song, G; Song, J | 1 |
Jiang, G; Li, M; Li, W; Liu, J; Liu, L; Owusu, L; Ren, B; Tang, Y; Zhang, J | 1 |
3 other study(ies) available for osthol and Cancer of Ovary
Article | Year |
---|---|
Osthole inhibits ovarian carcinoma cells through LC3-mediated autophagy and GSDME-dependent pyroptosis except for apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Line, Tumor; Coumarins; Female; Humans; Microtubule-Associated Proteins; Ovarian Neoplasms; Reactive Oxygen Species; Receptors, Estrogen | 2020 |
Osthole interacts with an ER-mitochondria axis and facilitates tumor suppression in ovarian cancer.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Coumarins; Endoplasmic Reticulum; Female; Humans; Mitochondria; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; Phosphatidylinositol 3-Kinase; Signal Transduction; Tumor Microenvironment; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays; Zebrafish | 2021 |
Anti-tumor effects of osthole on ovarian cancer cells in vitro.
Topics: Antineoplastic Agents; Apoptosis; CDC2 Protein Kinase; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Coumarins; Cyclin B1; Female; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis; Ovarian Neoplasms; Protease Inhibitors | 2016 |